Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer

Analytical Cellular Pathology

Volumn 24, Issue 4-5, 2002, Pages 147-158

  Wimberger, Pauline ^a   Hillemanns, Peter ^b   Kapsner, Thomas ^b   Hepp, Hermann ^b   Kimmig, Rainer ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DNA; FLUORESCEIN ISOTHIOCYANATE; KERATIN ANTIBODY;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LABELING; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; CURETTAGE; DNA DETERMINATION; ENDOMETRIUM CANCER; EPITHELIUM CELL; EVALUATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PARAMETER; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 0036962532     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/346969     Document Type: Article

References (42)

1. S.E. Shackney and T.V. Shankey, Common patterns of genetic evolution in human solid tumors, Cytometry 29 (1997), 1-27.
2. J. Sudbo, T. Ried, M. Bryne, W. Kldal, H. Danielsen and A. Reith, Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches, Oral Oncol. 37 (2001), 558-565.
3. J.C. Van der Linden, C.J. Herman, J.G. Boenders, M.M. van de Sandt and J. Lindeman, Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two-parameter analysis, Cytometry 13 (1992), 163-168.
4. R.J. Zarbo, D.W. Visscher and J.D. Crissman, Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen, Anal. Quant. Cytol. Histol. 11 (1989), 391-402.
5. H. Fox, Clinical value of new techniques of gynecological tumor assessment, Int. J. Gynecol. Cancer 7 (1997), 337-349.
6. A. Jakobsen, P. Bichel and M. Vaeth, New prognostic factors in squamous cell carcinoma of cervix uteri, Am. J. Clin. Oncol. 8 (1985), 39-43.
7. A. Leminen, J. Paavonen, E. Vesterinen, M. Forss, T. Wahlstrom, P. Kulomaa and M. Lehtinen, Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction, Am. J. Obstet. Gynecol. 162 (1990), 848-853.
8. H.N. Nguyen, B.U. Sevin, H.E. Averette, P. Ganjei, J. Perras, R. Ramos, R. Angioli, D. Donato and M. Penalver, The role of DNA index as a prognostic factor in early cervical carcinoma, Gynecol. Oncol. 50 (1993), 54-59.
9. T.E. Gudmundsson, T. Hodberg, P. Alm, H. Anderson, B. Baldetrop, M. Fernö E. Langstrom and D. Killander, The prognostic information of DNAA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma, Acta Oncol. 34 (1995), 803-812.
10. E. Kedar, B. Ikejiri, G.D. Bonnard and R.B. Herberman, A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses, Eur. J. Cancer Clin. Oncol. 18 (1982), 991-1000.
11. R. Kimmig, P. Wimberger, T. Kapsner and P. Hillemanns, Flow cytometric DNA analysis using cytokeratin labelling for identification of tumor cells in carcinomas of the breast and the female genital tract, Analyt. Cell. Pathol. 22 (2001), 165-178.
12. P. Wimberger, P. Hillemanns, T. Kapsner, H. Hepp and R. Kimmig, Evaluation of prognostic factors following flowcytometric DNA-analysis after cytokeratin labelling: I. Breast cancer, in press ACP (2002).
13. G.W. Snedecor and W. Cochran, Statistical Methods, 6th edn, The Iowa State University Press, Ames, Iowa, USA, 1973, pp. 327-329.
14. D. Hölzel, A. Klamert and M. Schmidt, Krebs, Häufigkeiten, Befunde und Behandlungsergebnisse. Perspektiven für die Krebsdiskussion und eine quantitative klinisch-epidemiologische Onkologie aus dem Tumorregister München, W. Zuckschwerdt Verlag, München, Bern, Wien, New York, 1996, pp. 297-352.
15. E. Burghardt, M.J. Webb, J.M. Monaghan and G. Kindermann, Cervical cancer, in: Surgical Gynecologic Oncology, Georg Thieme Verlag, Stuttgart, New York, 1993, pp. 185-333.
16. W. Kleine, Rau Kors., D. Schwoerer and A. Pfleiderer, Prognosis of the adenocarcinoma of the cervix uteri: a comparative study, Gynecol. Oncol. 35 (1989), 145-149.
17. H.M. Shingleton and J.W. Orr, The cytology and histopatholoy of cervical cancer, in: Cancer of the Cervix, J.B. Lippincott Company, Philadelphia, 1995, pp. 71-91.
18. D.J. Tinga, J.G. Bouma and J.G. Aalders, Patients with squamous cell versus adeno(squamous) carcinoma of the cervix, what fact determine the prognosis?, Int. J. Gynecol. Cancer 2 (1992), 83-91.
19. E. Burghardt, J. Baltzer, A.H. Tulusan and J. Haas, Results of surgical treatment of 1028 cervical cancers studied with volumetry, Cancer 70 (1992), 648-655.
20. R. McLellan, M.B. Dillon, J.D. Woodruff, G.J. Heatley, A.L. Fields and N.B. Rosenhein, Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery, Gynecol. Oncol. 52 (1994), 253-259.
21. R.J. Hale, W.D.J. Ryder, F.L. Wilcox, C.H. Buckley and V.R. Tindall, Cervical carcinoma: a hazard model in early stage disease, Int. J. Gynecol. Cancer 2 (1992), 79-82.
22. H. zur Hausen, Human genital cancer: synergism between two virus infections of synergism between a virus infection and initiating events?, Lancet 2 (1982), 1370-1372.
23. K. Seedorf, G. Krammer, M. Durst, S. Suhai and W.G. Rowekamp, Human papillomavirus type 16 DNA sequence, Virology 145 (1985), 181-185.
24. S.T. Cole and O. Danos, Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products, J. Mol. Biol. 193 (1987), 599-608.
25. R. De Vita, A. Calugi, F. Maggi, F. Mauro, L. Montevecchi and A. Vecchione, Flow cytometric DNA analysis of the human cervix affected by human papillomavirus and/or intraepithelial neoplasia, Anal. Quant. Cytol. Histol. 12 (1990), 306-313.
26. R.G. Steinbeck, Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis, Acta Oncol. 36 (1997), 3-12.
27. H.G. Hillemanns, H. Hilgarth, G. Göppinger and H. Ikenberg, Evaluation and dignity in CIN using DNA-cytometry and in situ hybridisation in HPV infections, Eur. J. Gynecol. Oncol. 8 (1987), 201-202.
28. H. zur Hausen, Viruses in human cancers, Science 254 (1991), 1167-1173.
29. P.M. Magtibay, J.F. Perrone, C.R. Stanhope, J.A. Katzmann, G.L. Keeney and H. Li, Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix, Gynecol. Oncol. 75 (1999), 242-247.
30. G.M. Zanetta, J.A. Katzmann, G.L. Keeney, W.K. Kinney, S.S. Cha and K.C. Podratz, Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma, Gynecol. Oncol. 46 (1992), 13-19.
31. J.P. Connor, D.S. Miller, K.D. Bauer, TM. Murad, A.W. Rademaker and J.R. Lurain, Flow cytometric evaluation of early invasive cervical cancer, Obstet. Gynecol. 81 (1993), 367-371.
32. G.B. Kristensen, L. Kaern, V.M. Abeler, B. Hagmar and C.G. Trope, No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of uterine cervix: a prospective study of 465 patients, Gynecol. Oncol. 57 (1995), 79-85.
33. D.H. Rutgers, P.M. van der Linden and H.A. van Peperzeel, DNA-flow cytometry of squamous cell carcinomas from the human uterine cervix: the identification of prognositcally different subgroups, Radiother. Oncol. 7 (1986), 249-258.
34. R. Willen, A. Himmelmann, E. Langstrom Einarsson, M. Fernö J. Ranstam, B. Baldetrop, J. Skjaeris, J. Prien Larsen, C. Trope and U. Stendahl, Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix, Anticancer Res. 13 (1993), 1187-1196.
35. J.E. Dyson, C.A. Joslin, R.I. Rothwell, P. Quirke, G.G. Khoury and C.C. Bird, Flow cytofluorometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours, Radiother. Oncol. 8 (1987), 263-272.
36. P.A. van Dam, J.V. Watson, D.G. Lowe and J.H. Shepherd, Flow cytometric DNA analysis in gynecologic oncolog, Int. J. Gynecol. Cancer 2 (1992), 57-65.
37. P.S. Braly, Flow cytometry as a prognostic factor in endometrial cancer - what does it add? [editorial; comment], Gynecol. Oncol. 58 (1995), 145-147.
38. J. Pfisterer, F. Kommoss, W. Sauerbrei, I. Rendl, M. Kiechle, W. Kleine and A. Pfleiderer, Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma [see comments], Gynecol. Oncol. 58 (1995), 149-156.
39. G. Wagenius, R. Bergstrom, P. Strang, U. Gerdes, K. Rogo, B. Tribukait and U. Stendahl, Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II, Anticancer. Res. 12 (1992), 725-732.
40. J.P. Geisler, M.C. Wiemann, Z. Zhou, G.A. Miller and H.E. Geisler, DNA index by image analysis in advanced endometrial carcinoma, J. Surg. Oncol. 63 (1996), 91-94.
41. A. Pasini, P. Corbella, E. Colombo, L. Redaelli and C. Belloni, Endometrial carcinoma: prognostic significance of cellular ploidy, Minerva Ginecol. 52 (2000), 179-184.
42. R. Kimmig, P. Wimberger, P. Hillemanns, T. Kapsner, C. Caspari and H. Hepp, Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells, Gynecol. Oncol. 84 (2002), 21-31.